Design, Synthesis, and Anti-Cancer Evaluation of Novel Water-Soluble Copper(I) Complexes Bearing Terpyridine and PTA Ligands
Molecules · 21.02.2024 · 29 (5) · 945
DOI: 10.3390/molecules29050945 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, online erschienen am 21.02.2024. Verfasst von Piotr Smoleński und 4 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Chemistry, University of Wrocław, F. Joliot-Curie 14, 50-383 Wrocław, Poland. Hauptthemen laut MEDLINE: Coordination Complexes, Antineoplastic Agents, Carcinoma, Organophosphorus Compounds. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Centre for Research and Development, NCBiR, Wrocław University of Environmental and Life Sciences.
Abstract (Originalsprache)
This study presents a simple and energy-efficient self-assembly LAG synthetic method for novel water-soluble copper(I) complexes [Cu(terpy)(PTA)][PF6] (1) and [Cu(terpy)(PTA)2][PF6] (2). They were characterized by FT-IR, 1H, and 31P{1H} NMR spectroscopy, elemental analysis, and single-crystal/powder X-ray diffraction (for 2). The X-ray analysis of compound 2 indicates a bidentate coordination mode of terpyridine to the metal center. Variable-temperature NMR tests indicate dynamic properties for terpyridine in the case of both compounds, as well as for the PTA ligands in the case of 2. Additionally, compounds 1 and 2 exhibit interesting cytotoxic activity, which was tested on normal human dermal fibroblasts (NHDFs), human lung carcinoma (A549), human breast adenocarcinoma (MCF-7), and human cervix carcinoma (HeLa) established cell lines. In comparison to the other tested compounds, complexes 1 and 2 seem to have significantly lower IC50 values against cancer cells (A549, HeLa, MCF-7), indicating their potential as prospective anticancer agents. Moreover, both compounds show no significant toxicity towards normal skin cells (NHDFs), suggesting a certain selectivity in their action on cancer cells. Cisplatin as a reference compound also exhibited considerable cytotoxicity against cancer cells but with a low level of selectivity, which could lead to unwanted effects on normal cells. Remarkably, compounds 1 and 2 exhibit up to 30 times the cytotoxic activity of cisplatin, with a six-fold lower toxicity to normal cells. They also interact strongly with human serum albumin, suggesting potential therapeutic applications. Overall, these compounds hold significant promise as potential chemotherapeutic agents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Chemistry, University of Wrocław, F. Joliot-Curie 14, 50-383 Wrocław, Poland.
- Department of Basic Chemical Sciences, Faculty of Pharmacy, Wrocław Medical University, Borowska 211a, 50-556 Wrocław, Poland.
- Department of Biostructure and Animal Physiology, Faculty of Veterinary Medicine, Wrocław University of Environmental and Life Sciences, Kożuchowska 1, 51-631 Wrocław, Poland.
ORCID-Profile: Anna Kwiecień, Dominik Poradowski
Förderung
- National Centre for Research and Development
- NCBiR
- Wrocław University of Environmental and Life Sciences
- Wrocław Medical University
Zitieren
APA
Smoleński, P., Śliwińska-Hill, U., Kwiecień, A., Wolińska, J., & Poradowski, D. (2024). Design, Synthesis, and Anti-Cancer Evaluation of Novel Water-Soluble Copper(I) Complexes Bearing Terpyridine and PTA Ligands. Molecules, 29(5), 945. https://doi.org/10.3390/molecules29050945
Vancouver
Smoleński P, Śliwińska-Hill U, Kwiecień A, Wolińska J, Poradowski D. Design, Synthesis, and Anti-Cancer Evaluation of Novel Water-Soluble Copper(I) Complexes Bearing Terpyridine and PTA Ligands. Molecules. 2024;29(5):945. doi:10.3390/molecules29050945
BibTeX
@article{Smoleski2024,
author = {Smoleński, Piotr and Śliwińska-Hill, Urszula and Kwiecień, Anna and Wolińska, Joanna and Poradowski, Dominik},
title = {Design, Synthesis, and Anti-Cancer Evaluation of Novel Water-Soluble Copper(I) Complexes Bearing Terpyridine and PTA Ligands},
journal = {Molecules},
year = {2024},
volume = {29},
number = {5},
pages = {945},
doi = {10.3390/molecules29050945}
}
EUVIMED